Fresenius Medical Care Corporation (NYSE: FMS) and Concord Medical Services Holdings Limited (NYSE:CCM) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.

Profitability

This table compares Fresenius Medical Care Corporation and Concord Medical Services Holdings Limited’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Fresenius Medical Care Corporation 7.06% 11.57% 4.97%
Concord Medical Services Holdings Limited N/A N/A N/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Fresenius Medical Care Corporation and Concord Medical Services Holdings Limited, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care Corporation 0 3 7 0 2.70
Concord Medical Services Holdings Limited 0 0 0 0 N/A

Fresenius Medical Care Corporation presently has a consensus price target of $46.00, suggesting a potential downside of 5.09%. Given Fresenius Medical Care Corporation’s higher possible upside, equities analysts plainly believe Fresenius Medical Care Corporation is more favorable than Concord Medical Services Holdings Limited.

Volatility & Risk

Fresenius Medical Care Corporation has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Comparatively, Concord Medical Services Holdings Limited has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500.

Valuation & Earnings

This table compares Fresenius Medical Care Corporation and Concord Medical Services Holdings Limited’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Fresenius Medical Care Corporation $20.52 billion 1.45 $3.75 billion $2.18 22.23
Concord Medical Services Holdings Limited $61.54 million 2.84 -$8.19 million ($0.67) -5.97

Fresenius Medical Care Corporation has higher revenue and earnings than Concord Medical Services Holdings Limited. Concord Medical Services Holdings Limited is trading at a lower price-to-earnings ratio than Fresenius Medical Care Corporation, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

2.6% of Fresenius Medical Care Corporation shares are held by institutional investors. Comparatively, 12.6% of Concord Medical Services Holdings Limited shares are held by institutional investors. 46.5% of Concord Medical Services Holdings Limited shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Dividends

Fresenius Medical Care Corporation pays an annual dividend of $0.37 per share and has a dividend yield of 0.8%. Concord Medical Services Holdings Limited does not pay a dividend. Fresenius Medical Care Corporation pays out 17.0% of its earnings in the form of a dividend.

Summary

Fresenius Medical Care Corporation beats Concord Medical Services Holdings Limited on 9 of the 14 factors compared between the two stocks.

Fresenius Medical Care Corporation Company Profile

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment. The Company develops and manufactures a range of dialysis machines, systems and disposable products. As of December 31, 2016, the Company sold its products to customers in more than 120 countries and also used in its internal healthcare service operations. The Company’s Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services, ambulatory surgery center services and urgent care services.

Concord Medical Services Holdings Limited Company Profile

Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company’s segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. Its network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers. The Company’s cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner.

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.